ABL Bio (XKRX:298380) Interest Expense : ₩-1,487 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ABL Bio's interest expense for the three months ended in Mar. 2024 was ₩ -10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,487 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ABL Bio's Operating Income for the three months ended in Mar. 2024 was ₩ -14,278 Mil. ABL Bio's Interest Expense for the three months ended in Mar. 2024 was ₩ -10 Mil. ABL Bio did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ABL Bio Interest Expense Historical Data

The historical data trend for ABL Bio's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Interest Expense Chart

ABL Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-90.73

-72.85

-41.98

-1,325.98

-2,150.65

ABL Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-673.20	-643.08	-651.33	-183.04	-9.60

ABL Bio Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,487 Mil.

ABL Bio (XKRX:298380) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ABL Bio's Interest Expense for the three months ended in Mar. 2024 was ₩-10 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩-14,278 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩43,071 Mil.

ABL Bio's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

ABL Bio did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

ABL Bio (XKRX:298380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

https://www.ablbio.com

ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines